286 related articles for article (PubMed ID: 24057864)
21. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability.
Esfandiarei M; Boroomand S; Suarez A; Si X; Rahmani M; McManus B
Cell Microbiol; 2007 Oct; 9(10):2358-71. PubMed ID: 17848167
[TBL] [Abstract][Full Text] [Related]
22. Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus myocarditis.
Liu T; Zhang M; Niu H; Liu J; Ruilian M; Wang Y; Xiao Y; Xiao Z; Sun J; Dong Y; Liu X
Int J Biol Macromol; 2019 Apr; 126():179-186. PubMed ID: 30586589
[TBL] [Abstract][Full Text] [Related]
23. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
[TBL] [Abstract][Full Text] [Related]
24. LncGBP9 knockdown alleviates myocardial inflammation and apoptosis in mice with acute viral myocarditis via suppressing NF-κB signaling pathway.
Xue Y; Zhang J; Ke J; Zeng L; Cheng K; Han X; Chen F; Chen F
Inflamm Res; 2022 Dec; 71(12):1559-1576. PubMed ID: 36301340
[TBL] [Abstract][Full Text] [Related]
25. Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression.
Chen J; Wang Z; Wu T
Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1826-34. PubMed ID: 23374452
[TBL] [Abstract][Full Text] [Related]
26. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
27. Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways.
Qi S; Xin Y; Guo Y; Diao Y; Kou X; Luo L; Yin Z
Int Immunopharmacol; 2012 Jan; 12(1):278-87. PubMed ID: 22193240
[TBL] [Abstract][Full Text] [Related]
28. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-kappaB inhibitor.
Matsumori A; Nunokawa Y; Yamaki A; Yamamoto K; Hwang MW; Miyamoto T; Hara M; Nishio R; Kitaura-Inenaga K; Ono K
Eur J Heart Fail; 2004 Mar; 6(2):137-44. PubMed ID: 14984720
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
Zhu H; Lou C; Liu P
Virol J; 2015 Nov; 12():189. PubMed ID: 26578236
[TBL] [Abstract][Full Text] [Related]
30. Curcumin attenuates high glucose-induced inflammatory injury through the reactive oxygen species-phosphoinositide 3-kinase/protein kinase B-nuclear factor-κB signaling pathway in rat thoracic aorta endothelial cells.
Zhang Z; Li K
J Diabetes Investig; 2018 Jul; 9(4):731-740. PubMed ID: 29080256
[TBL] [Abstract][Full Text] [Related]
31. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
[TBL] [Abstract][Full Text] [Related]
32. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
33. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice.
Shi Y; Pan H; Zhang HZ; Zhao XY; Jin J; Wang HY
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1850-1859. PubMed ID: 28485793
[TBL] [Abstract][Full Text] [Related]
34. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
35. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
[TBL] [Abstract][Full Text] [Related]
37. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
38. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R
J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214
[TBL] [Abstract][Full Text] [Related]
39. In vivo delivery of interleukin-35 relieves coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
Hu Y; Dong C; Yue Y; Xiong S
Arch Virol; 2014 Sep; 159(9):2411-9. PubMed ID: 24788848
[TBL] [Abstract][Full Text] [Related]
40. H-RN, a novel antiangiogenic peptide derived from hepatocyte growth factor inhibits inflammation in vitro and in vivo through PI3K/AKT/IKK/NF-κB signal pathway.
Wang L; Xu Y; Yu Q; Sun Q; Xu Y; Gu Q; Xu X
Biochem Pharmacol; 2014 May; 89(2):255-65. PubMed ID: 24630926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
